We recently published a list of 12 Most Buzzing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Microsoft Corporation (NASDAQ:MSFT) stands against other ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

Truist Securities adjusted their financial outlook for Axsome Therapeutics (NASDAQ:AXSM), increasing the price target to $190 from the previous $180 while maintaining a Buy rating on the company's ...

Today's market activity can be summed up in a word: fear. After beginning their decent late in the day on Friday, stocks have ...

The U.S. stock markets have fallen after an early selloffs over fears of President Donald Trump’s new tariffs on Canada, ...

Stock markets are reacting sharply after US President Donald Trump announced new tariffs on imports from Mexico, Canada, and ...

We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

Nvidia (NASDAQ: NVDA) replaced Intel in the Dow Jones Industrial Average. The swap gave the value-focused index more exposure ...

Nvidia (NASDAQ: NVDA) stock took a haircut recently after China-based startup DeepSeek announced the success of its R1 model ...

In a turbulent market session, VIRX, the stock of Sunesis Pharmaceuticals (NASDAQ:VIRX), plummeted to a 52-week low, reaching a distressing price level of $0.08. According to InvestingPro data, the ...

Macrogenics Inc. (NASDAQ:MGNX) stock has tumbled to a 52-week low, touching down at $2.91, as the biopharmaceutical company faces a challenging period marked by investor concerns. According to ...

Let's take a look. The post Can Nvidia stock still hit $200 in 2025? appeared first on The Motley Fool Australia.